A review on advances in 18F-FDG PET/CT radiomics standardisation and application in lung disease management
Radiomics analysis quantifies the interpolation of multiple and invisible molecular features
present in diagnostic and therapeutic images. Implementation of 18-fluorine …
present in diagnostic and therapeutic images. Implementation of 18-fluorine …
2-[18F] FDG PET/CT radiomics in lung cancer: An overview of the technical aspect and its emerging role in management of the disease
Lung cancer is the most common cancer, worldwide, and a major health issue with a
remarkable mortality rate. 2-[18 F] fluoro-2-deoxy-D-glucose positron emission …
remarkable mortality rate. 2-[18 F] fluoro-2-deoxy-D-glucose positron emission …
Can multimodality imaging using 18F-FDG/18F-FLT PET/CT benefit the diagnosis and management of patients with pulmonary lesions?
B Xu, Z Guan, C Liu, R Wang, D Yin, J Zhang… - European journal of …, 2011 - Springer
Abstract Purpose Dual-tracer, 18 F-fluorodeoxyglucose and 18 F-fluorodeoxythymidine (18
F-FDG/18 F-FLT), dual-modality (positron emission tomography and computed tomography …
F-FDG/18 F-FLT), dual-modality (positron emission tomography and computed tomography …
Role of 18F-FDG-PET/CT in establishing new clinical and therapeutic modalities in lung cancer. a short review
RCD Bolton, AK Calapaquí-Terán, F Giammarile… - Revista Española de …, 2019 - Elsevier
Lung cancer is a fairly common malignancy. An early diagnosis and a reliable staging and
re-staging with the aim to detect both local and distant relapse are of utmost importance in …
re-staging with the aim to detect both local and distant relapse are of utmost importance in …
Consensus recommendations on the use of 18F-FDG PET/CT in lung disease
DL Chen, S Ballout, L Chen, J Cheriyan… - Journal of Nuclear …, 2020 - Soc Nuclear Med
PET with 18F-FDG has been increasingly applied, predominantly in the research setting, to
study drug effects and pulmonary biology and to monitor disease progression and treatment …
study drug effects and pulmonary biology and to monitor disease progression and treatment …
18F-FDG PET/MRI in Detection of Pulmonary Malignancies: A Systematic Review and Meta-Analysis
SA Mirshahvalad, U Metser, A Basso Dias, C Ortega… - Radiology, 2023 - pubs.rsna.org
Background There have been conflicting results regarding fluorine 18–labeled
fluorodeoxyglucose (18F-FDG) PET/MRI diagnostic performance in lung malignant …
fluorodeoxyglucose (18F-FDG) PET/MRI diagnostic performance in lung malignant …
Radiomic analysis will add differential diagnostic value of benign and malignant pulmonary nodules: a hybrid imaging study based on [18F]FDG and [18F]FLT PET …
Purpose To investigate the clinical value of radiomic analysis on [18F] FDG and [18F] FLT
PET on the differentiation of [18F] FDG-avid benign and malignant pulmonary nodules …
PET on the differentiation of [18F] FDG-avid benign and malignant pulmonary nodules …
Quantification of lung PET images: challenges and opportunities
Millions of people are affected by respiratory diseases, leading to a significant health burden
globally. Because of the current insufficient knowledge of the underlying mechanisms that …
globally. Because of the current insufficient knowledge of the underlying mechanisms that …
PET/MRI and PET/CT in lung lesions and thoracic malignancies
P Flechsig, A Mehndiratta, U Haberkorn… - Seminars in nuclear …, 2015 - Elsevier
More than one decade ago, introduction of integrated PET/CT scanners changed oncologic
imaging and oncologic patient management profoundly. With these systems, the metabolic …
imaging and oncologic patient management profoundly. With these systems, the metabolic …
Current status and prospect of PET-related imaging radiomics in lung cancer
X Tang, F Wu, X Chen, S Ye, Z Ding - Frontiers in Oncology, 2023 - frontiersin.org
Lung cancer is highly aggressive, which has a high mortality rate. Major types encompass
lung adenocarcinoma, lung squamous cell carcinoma, lung adenosquamous carcinoma …
lung adenocarcinoma, lung squamous cell carcinoma, lung adenosquamous carcinoma …